NDC 33342-585-12
dapagliflozin 5 mg/1
dapagliflozin · TABLET
Dapagliflozin is an oral tablet used to treat type 2 diabetes and certain heart and kidney conditions by helping your body remove excess glucose through urine. It belongs to a class of medications called sodium-glucose cotransporter 2 inhibitors.
Key Facts
- Brand Name
- dapagliflozin
- Generic Name
- dapagliflozin
- NDC Code (Package)
33342-585-12- NDC Code (Product)
33342-585- Manufacturer
- Macleods Pharmaceuticals Limited
- Strength
- 5 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- ANDA211506
- Drug Class
- Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
- Marketing Start
- 04/06/2026
Recall History
No Recall HistoryView Full Drug Page
dapagliflozin — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.